CRNX

Crinetics Pharmaceuticals (CRNX) Investor Questions

Review Crinetics Pharmaceuticals (CRNX) faq with server-rendered company data, supporting context and links to related investor research.

Company
Crinetics Pharmaceuticals
Sector
Healthcare
Industry
Biotechnology
Overall BTI score
56
Annual revenue
$7.70M
Annual net income
$-465.32M
Annual free cash flow
$-383.68M

Crinetics Pharmaceuticals (CRNX) Investor Questions research

Crinetics Pharmaceuticals trades under the ticker CRNX. The company is classified in the Healthcare sector and the Biotechnology industry.

Investors commonly review CRNX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.